FDA Announces The Discontinuation Of Certain COVID-19-Relate

In the wake of the Department of Health and Human Services' (HHS) February announcement that they will be discontinuing the COVID-19 public health emergency (PHE) declaration on May 11, 2023...

Related Keywords

United States , , Coagulation Systems For Measurement Of Viscoelastic Properties , Health Care , Guidance Documents Expiring With The Public Health , Expiration Of The Public Health Emergency , Development Of Monoclonal Antibody Products , Health Emergency , Public Health Emergency , Public Health Emergency Guidance , Enforcement Policy For Digital Health Devices , Human Services , Development Of Abbreviated New Drug Applications During , Drug Administration , Party Certification , Public Health Emergency Guidance For Industry , Public Health , Animal Drug Development , Department Of Health , Health Emergency Guidance For Industry , Public Health Emergency On , Program Onsite Observation , United States Food , Federal Register , Resuming Normal Drug , Manufacturing Operations During , Health Emergency Guidance , Digital Health Devices , Treating Psychiatric Disorders During , Coronavirus Disease , Non Invasive Fetal , Maternal Monitoring Devices Used , Support Patient Monitoring , Use Authorization , Monoclonal Antibody Products , Including Addressing , Non Invasive Remote , Monitoring Devices Used , Support Patient Monitoring During , Postmarketing Adverse Event Reporting , Medical Products , Dietary Supplements During , Documents Subject , Documents Expiring With , Gene Therapy Products During , Health Emergency Policy , Mitigating Nonhuman Primate , Supply Constraints Arising , Abbreviated New Drug Applications During , Bioequivalence Studies , Applicant Responses , Complete Response , Letters When , Facility Assessment , Needed During , Normal Drug , Biologics Manufacturing Operations , Manufacturing Practice Considerations , Biological Products , Clinical Trials During , User Fee Applications , Certain Drugs , Hospitalized Patients , Outsourcing Facilities During , Pharmacy Compounders , Sterile Compounding , Prescription Drug Marketing Act Requirements , Drug Samples During , General Considerations , Certain Requirements , Supply Chain Security Act During , Permanent Discontinuance , Device Under Section , Quality Standards , Quality Standards Act During , Policy Regarding Enforcement , Egg Safety Rule , Policy Regarding Packaging , Shell Eggs , Retail Food Establishments During , Policy Regarding Nutrition Labeling , Packaged Food During , Temporary Closure , Significantly Reduced , Human Food Establishment , Assistance During , Documents Discontinuing , Temporary Use , Portable Cryogenic Containers , Compliance With , Supply Chain , Biological Product , Inspections During , Health Emergency Questions , Standard Menu , Chain Restaurants , Similar Retail Food Establishments , Minor Formulation , Policy During , Qualified Exemption , Support New Animal Drug Development , Policy Guidance Documents Continuing , Longer After , Remote Digital Pathology Devices During , Imaging Systems During , Telethermographic Systems During , Psychiatric Disorders During , Extracorporeal Membrane Oxygenation , Cardiopulmonary Bypass Devices During , Remote Ophthalmic Assessment , Monitoring Devices During , Infusion Pumps , Accessories During , Face Shields , Surgical Masks , Respirators During , Gloves During , Disinfectant Devices , Air Purifiers During , Respiratory Devices During , Viscoelastic Properties , Enforcement Policy During , Viral Transport Media During , Revise Within , Immunodeficiency Virus Transmission , Blood Components During , Clinical Trials , Developing Drugs , Isopropyl Alcohol , Including During , Potency Assay Considerations , Monoclonal Antibodies , Related Symptoms , Outpatient Adult , Adolescent Subjects , Review Board , Individual Patient , Expanded Access Requests , Investigational Drugs , Products During , Manufacturing Under Section , Fact Guidance , Master Protocols Evaluating Drugs , Interactive Evaluations , Drug Manufacturing , Bioresearch Monitoring Facilities During , Emergency Guidance , Closure System , Component Changes , Stoppers Guidance , Monoclonal Antibody Products Targeting , Face Masks , Barrier Face Coverings , Approved Premarket Approval , Humanitarian Device Exemption , Submissions During , Clinical Electronic Thermometers During , Non Invasive Remote Monitoring Devices , Refrigerated Transport Vehicles , Storage Units , Food Uses After Using Them , Preserve Human , Remains During , Policy Regarding Preventive Controls , Certificate Duration Requirements , Mitigating Animal Drug Shortages , Documents That Will Remain , Post Public Health , Specific Guidances , Adverse Event Reporting , Evaluating Impact , Viral Mutations , Mondaq , Fda Announces The Discontinuation Of Certain Covid 19 Related Guidance Documents , Coronavirus Covid 19 , Government Measures , Operational Impacts And Strategy , Food , Drugs , Healthcare , Life Sciences , Food And Drugs Law , Iotechnology Amp Nanotechnology ,